about
Oral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control?Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseaseNatural products as sources of new drugs over the 30 years from 1981 to 2010Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compoundsCombination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature.GPR119 agonists 2009-2011.Physiological mechanisms for the increase in renal solute-free water clearance by a glucagon-like peptide-1 mimetic.
P2860
Q27023585-6E77DAB4-D125-4637-9954-AB2001CB1BECQ27027920-CF86C89B-5C6A-499A-B12E-02C7E0077122Q29616640-D8374400-44F7-4AF0-9114-A303B2B05E05Q36801780-BDF17FFE-5456-406A-87E3-048229422445Q36872178-0E3E982B-11F3-4ACF-A4A4-96A73DCD3F10Q38162927-DA52C19B-A4B5-49E2-ADBA-E4E9DEC3DDE6Q50974989-88CE7DB3-AC5B-4ADB-95CE-3E65A21899C5
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
GLP-1 receptor agonists today.
@en
GLP-1 receptor agonists today.
@nl
type
label
GLP-1 receptor agonists today.
@en
GLP-1 receptor agonists today.
@nl
prefLabel
GLP-1 receptor agonists today.
@en
GLP-1 receptor agonists today.
@nl
P1476
GLP-1 receptor agonists today.
@en
P2093
Alfred Penfornis
P304
P356
10.1016/J.DIABRES.2011.01.004
P50
P577
2011-07-20T00:00:00Z